Skip to main content

Media Coverage

Media Coverage

How can Artera bootstrap a new AWS region within hours?

Setting up the infrastructure for a product line in an entirely new region with over 340 distinct AWS resources could easily [...]

Read more

Media Coverage

Doctors Explain What Prostate Cancer Screenings Involve

If you've never had a prostate cancer screening, you may worry that it will be embarrassing and uncomfortable. Doctors say th [...]

Read more

Media Coverage

ArteraAI Prostate Test Included in NCCN Guidelines

The National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines for Prostate Cancer have included the ArteraAI [...]

Read more

Media Coverage

Here’s how AI will drive health care to meet consumer expectations

The rapid transformation of the health care landscape is undeniable. It is marked not only by groundbreaking technologies and [...]

Read more

Media Coverage

Exclusive: ArteraAI nabs $20M to take personalized cancer care global

ArteraAI, a developer of AI tests to personalize therapy for cancer patients, raised $20 million in additional funding, CEO A [...]

Read more

Media Coverage

Can AI-Driven Cancer Care Help Improve Mental Well-Being?

AI-enabled predictive and prognostic tests allow clinicians a line of sight.

Read more

Media Coverage

Prostate cancer myths and common misconceptions from an oncologist amid high-profile cases

Amid a flurry of high-profile prostate cancer announcements, doctors are weighing in to debunk common myths about the disease [...]

Read more

Media Coverage

CMS payment rate established for ArteraAI prostate cancer test

The Centers for Medicare & Medicaid Services (CMS) have established a payment rate for the ArteraAI prostate cancer test, [...]

Read more

Media Coverage

Startups Are Using AI to Predict Responses to Cancer Drugs

Biomedical startups are using artificial intelligence to predict the response patients will have to cancer treatments, aiming [...]

Read more

1 2 3 4 5 6 7